American College of Diabetology

American College of Diabetology There are currently 6 diabetes fellowship programs in the United States. They have been in existence for over 10 years.

The American College of Diabetology is a physician led nonprofit organization passionate about management of diabetes mellitus with the goal of maintaining high standards in diabetes clinical care, to improve the lives of those affected by diabetes. The CDC has projected that 1 in 3 Americans will develop diabetes should the current trends continue. There are not enough endocrinologists to meet this need and Primary care physicians are overburdened with the other chronic diseases of a patient. Our goal is to train physicians with excellent diabetes management skills to fight this epidemic. Please seen our websites for more information. Ohio University: www.ohio.edu/diabetes/clinicalfellowship

East Carolina University: http://www.ecu.edu/cs-dhs/im/Endocrinology/diabetesfellowship.cfm

In a recent Medscape Medical News article, Joshua Neumiller, PharmD, CDCES, discusses the increased risk of prediabetes ...
09/18/2026

In a recent Medscape Medical News article, Joshua Neumiller, PharmD, CDCES, discusses the increased risk of prediabetes and diabetes among people with HIV and how some antiretroviral therapies can contribute to insulin resistance and elevated blood glucose.

He also highlights an important consideration for clinicians: people with both HIV and diabetes face heightened cardiovascular and kidney risks, making risk reduction a key treatment objective.

The full article explores what clinicians should know about monitoring and managing diabetes in people with HIV — and why comprehensive, multidisciplinary care matters.

The future of diabetes care raises some important questions.These are just a few of the questions we’ll explore at the 4...
09/15/2026

The future of diabetes care raises some important questions.

These are just a few of the questions we’ll explore at the 4th Annual ACD Conference, where clinicians, researchers and diabetes care professionals will come together to examine the evolving landscape of diabetology.

Which question are you most looking forward to exploring?

09/10/2026

We’re counting down the days! ⏰ Just two weeks until the 4th Annual ACD Conference!

💡 Hear from renowned industry speakers at the forefront of the field.
🤝 Grow your network by connecting with colleagues.
🔬 Get hands-on experience with the latest diabetes technologies.

We can’t wait to see you in Columbus!

Diabetes technology continues to transform care for those living with diabetes, but innovation can come with challenges,...
09/08/2026

Diabetes technology continues to transform care for those living with diabetes, but innovation can come with challenges, too.

Dr. David Ahn recently spoke with Medscape about new research that examines the real-world burden of CGMs, insulin pumps and automated insulin delivery (AID) systems.

Understanding the challenges those with T1D experience when using these technologies is an important part of delivering better care and improving outcomes.

Read the full article via the link in the comments.

A recent Endocrine Today article asserts that fracture risk assessments should enter diabetes care conversations earlier...
09/04/2026

A recent Endocrine Today article asserts that fracture risk assessments should enter diabetes care conversations earlier.

New research found that individuals with type 1 diabetes have more than double the fracture risk compared to those without diabetes, and that risk starts as early as ages 10-19. Those with diabetic kidney disease have up to five times higher risk for fractures.

View the comment section to read the full study.

Mark your calendars for our next Case of the Month session! Join us as Dr. Viral Shah presents Defining and Predicting H...
09/02/2026

Mark your calendars for our next Case of the Month session! Join us as Dr. Viral Shah presents Defining and Predicting Hypoglycemia.

The session will include a 30-minute presentation followed by an interactive Q&A designed for diabetology fellows, ACD members and others looking to expand their knowledge in the field.

📆Wednesday, September 9
⏰ 2 PM EST | 1 PM CST | 12 PM MST | 11 AM PST

Dr. Shah is widely sought as an expert on diabetes care and technology. He is an internationally recognized diabetes researcher, Professor of Medicine and Director of Diabetes Clinical Research at Indiana University.

Save your spot via this link: https://bit.ly/4twtqrb

Participation in the live questionnaire session and access to the recorded video is exclusive to ACD members. To become a member, visit our website.

3 weeks until we head to Columbus! 🎉Finalizing your agenda for the 4th Annual ACD Conference? We’ve identified a few loc...
09/01/2026

3 weeks until we head to Columbus! 🎉

Finalizing your agenda for the 4th Annual ACD Conference? We’ve identified a few local favorites to add to your itinerary while you're in town, including award-winning restaurants & cafes, local spots for craft goods and the best places for scenic views.

Round out your trip and make the most of Columbus while you're here for the conference!

There’s still time to register — link in the comments section.

Emerging evidence suggests the relationship between diabetes and cancer may be more nuanced. While poor glycemic control...
08/28/2026

Emerging evidence suggests the relationship between diabetes and cancer may be more nuanced. While poor glycemic control is associated with increased risk, Mendelian randomization data point to hyperinsulinemia as a potential driver across several types of cancer.

What does this mean for how clinicians think about diabetes and cancer risk in practice? Dr. Zehra Haider breaks down the latest evidence in her blog post, “Diabetes and Cancer Risk: What the Latest Evidence Means for Clinical Practice.” Head to the comments section to read the full piece.

As T1D care evolves, earlier intervention and more personalized treatment are becoming possible. Kimber Simmons, MD, MS,...
08/25/2026

As T1D care evolves, earlier intervention and more personalized treatment are becoming possible.

Kimber Simmons, MD, MS, recently spoke with Endocrine Today about screening, Teplizumab and the future of T1D treatment. She’ll continue the conversation at the 4th Annual ACD Conference with her presentation, “Immune Modulation: Teplizumab.”

Read the full article via the link in the comments.

Meet the 4th Annual ACD Conference Keynote Speaker! 👋With a career spanning diabetes research, clinical care and the tra...
08/20/2026

Meet the 4th Annual ACD Conference Keynote Speaker! 👋

With a career spanning diabetes research, clinical care and the translation of emerging sciences into practice, we’re excited for the valuable insights Dr. Pratley will share about the evolving diabetes care landscape and what’s ahead for the field.

We’ll see you in Columbus next month!

Address

American College Of Diabetology PO Box 87633
Fayetteville, NC
28304

Alerts

Be the first to know and let us send you an email when American College of Diabetology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to American College of Diabetology:

Shortcuts

Share